In Focus

Current topic

---

08/5/2013
Future of Family Planning

More than 200 million women and girls in developing countries have no access to modern contraceptives or other family-planning services – even though they would use contraception if they could. 80 million women get pregnant unintentionally every year. One woman dies of pregnancy or childbirth complications every two minutes. A large proportion of these women live in developing countries.

more

Further information and background details

---

27/2/2013
From the idea to the contract

A global initiative improves access to reliable and effective contraception for 27 million women
More than 200 million women in developing countries have no access to modern contraceptives or other services supporting active family planning – even though they would like to use contraception. An agreement between Bayer HealthCare and the Bill & Melinda Gates Foundation signed in December will improve access to a safe and reversible form of long-term contraception: Jadelle. This implant, which was prequalified by the World Health Organization in 2009, offers women effective contraception for up to five years. The program expects to prevent almost 30 million unplanned pregnancies and to save $250 million in global healthcare costs during the term of the agreement between 2013 and 2018.

link more

---

25/2/2013
Joint search for new medicines

Bayer HealthCare coordinates an international consortium called “European Lead Factory”
The European Lead Factory will create an exceptional library collection of small molecules with the aim of enhancing early drug discovery and developing innovative drugs. Bayer HealthCare initiated and will coordinate the newly founded pan-European consortium. It is structured as a public-private partnership and is supported by Europe’s Innovative Medicines Initiative (IMI).

more

---

11/7/2012
Population dynamics in the 21st century
10th International Dialogue in Berlin
For the tenth time, the international Dialogue on Population and Sustainable Development was held in Berlin on 24th and 25th October. more

---

4/24/2012
Focus on Girls – Worldwide: Parliamentary Evening supported by Bayer HealthCare Pharmaceuticals and organized by the German Foundation for World Population
Equal opportunities are a human right, yet girls are still being disadvantaged: they suffer discrimination, are exposed to special health risks, are more frequently victims of violence, and have less access to education. more

---

3/24/2012
24 March - World Tuberculosis Day
Bayer HealthCare Pharmaceuticals supports the WHO and the TB Alliance in the fight against one of the most deadly infectious diseases in the world.

30 years after discovery of the tuberculosis bacterium, it has still not been possible to eradicate tuberculosis. According to the WHO, the disease claimed 1.7 million lives in 2009 or to put it another way 4,700 people died of tuberculosis every day. The developing countries and emerging markets China and India are particularly affected. We are a committed partner in the fight against this terrible disease. more

---

02/16/2012
Successful together in the fight against neglected tropical diseases
13 pharmaceutical companies, the governments of the United States, the UK, and the United Arab Emirates, the Bill & Melinda Gates Foundation, the World Bank and other global health organizations all have a clear goal: to take new, coordinated measures to accelerate progress toward the eradication or containment of ten neglected tropical diseases (NTDs) by the end of the decade. This was announced on January 30, 2012, in London by the parties involved, one of which was Bayer HealthCare. more

---

11/15/2011
9th International Dialogue on Population and Sustainable Development
“Education Matters: Empowering Young People to Make Healthier Choices”

At the time when the 7 billionth human war born, the 9th International Dialogue on Population and Sustainable Development took place in Berlin. Politicians, representatives from governmental and non-governmental organizations, scientists and young people discussed under the slogan “Education Matters: Empowering Young People to Make Healthier Choices”. more

---

09/29/2011
Better access to safe and affordable contraception in Uganda
Partnership between Bayer and USAID provides broad sections of the population in Uganda a better access to oral contraceptives

In Uganda, as in other African countries, there is a considerable demand for contraceptives to enable a self-determined family planning, to avoid unwanted or risky pregnancies and to improve the health of mothers and children. more

---

09/09/2011
Methodological manual for sex education presented in Uganda
Bayer and DSW have jointly developed an innovative project on sex education

On September 8, 2011, the German Foundation for World Population (DSW) presented an innovative manual on the sex education of boys and girls aged ten to fourteen in Uganda. The presentation in the capital Kampala was attended by the representative of UNFPA in Uganda, several ministers, ambassadors and representatives of partner organizations. more

---

20/04/2011
Women’s Healthcare as a Human Right: the Bayer HealthCare Pharmaceuticals parliamentary forum
Every year 350,000 women worldwide die during childbirth and from complications during pregnancy because there is not enough medical assistance for them. A majority of these women are in developing countries where the situation is especially critical. more

---

01/03/2011
Rare Disease Day 2011: Bayer HealthCare Pharmaceuticals supports campaign for Pulmonary Hypertension
What do you do when you suffer from a disease that seems to affect no one but yourself? What do you do if even doctors do appear not to know it well? A disease which is so rare that science has to think twice before finally deciding to begin the search for appropriate therapies. A disease for which diagnostics and therapies rarely exist or are insufficient and it may take years before a diagnosis can be finally confirmed. more

---

13/01/2011
We cooperate with USAID to create sustainable contraceptive market in Africa
More than 215 Million women worldwide would like to use a contraceptive method, being able to choose the size of their family. However, in developing countries not all women do have access to modern contraceptive methods. With the help of the new “Contraceptive Security Initiative” women with middle income in 11 nations of sub-Saharan Africa will have access to oral contraceptives at affordable prices. more

---

10/27/2010
8th International Dialogue on Population and Sustainable Development 2010
Actually, the issue of development aid can be quite a fun topic. For example when Huzeifa Bodal from the German Agency for Technical Cooperation (GTZ) smiles and says that efforts to promote the sexual self-determination of women in developing countries need to be presented in a "sexier" way, so that the public pays more attention to the issue. more

---

10/20/2010
World Health Summit: Improving global access to medical research
The second World Health Summit was held in Charité Berlin on October 10 to 13, 2010, supported by Bayer Schering Pharma as one of its general partners. This year’s summit was held under the patronage of Angela Merkel, Chancellor of the Federal Republic of Germany, and Nicolas Sarkozy, President of the French Republic. more

---

09/24/2010
World Heart Day 2010
Cardiovascular disease (CVD) remains the No. 1 cause of death worldwide – annually claiming 17 million people all over the world. This number is estimated to rise to 20 million by 2015. more

---

08/13/2010
Bayer Schering Pharma supports special training for doctors in Tibet
It’s hard to visit a doctor in rural Tibet. With better local health care, there’s less need for costly trips to distant medical centres: 40 Doctors from across Tibet are preparing to go back to their rugged rural clinics armed with new skills and techniques gained through training sponsored in part by Bayer Schering Pharma. more

---

06/24/2010
IMI – Innovative Medicines Initiative: Project Eu2P
Pharmaceutical companies and academic institutions have come together in the IMI and are jointly developing both a European master's degree course and a three-year doctorate program in this important field. This is the Eu2P project (European Program in Pharmacovigilance and Pharmacoepidemiology). more

---

05/26/2010
Bayer Schering Pharma launches drawing competition for young people impacted by MS
On World MS day, May 26th, Bayer Schering Pharma has launched of the Dreams for My Family contest for young artists impacted by MS. The global art competition allows children whose lives are affected by multiple sclerosis (MS) to express their future dreams for their families. more

---

04/30/2010
IMI – Innovative Medicines Initiative
The SAFESCIMET project: a new master's degree course to train experts in drug safety more

---

03/23/2010
On March 24 is World Tuberculosis Day
The fight against tuberculosis (TB), which tops the global statistics of fatal infectious diseases, is one of the greatest medical challenges of all. Someone dies of tuberculosis about every 20 seconds; this corresponds to almost 5,000 people every day. more

---

02/22/2010
IMI – Innovative Medicines Initiative
EMTRAIN: European platform for new educational and training programs in pharmaceutical medicine more

---

12/15/2009
IMI – Innovative Medicines Initiative
SAFE-T Project: researchers search for biomarkers to improve the early detection of drug-induced organ damage more

---

12/03/2009
Bayer Team wins the “Deutscher Zukunftspreis” awarded by the German President
German Federal President Horst Köhler praises outstanding innovation achievement / Development of the novel oral anticoagulant rivaroxaban commended more

---

11/30/2009
Sex education protects people against AIDS
When you talk about AIDS, you have to talk about sex. We know how important sex education is from our many years of experience in the field of hormonal contraception. Our attitude toward sex education is not limited to the issue of contraception, however, but also encompasses a responsible way of dealing with oneself and one’s body in general. more

---

10/19/2009
First World Health Summit took place in Berlin
The first World Health Summit took place from October 14 – 18, 2009 in Berlin under the heading “The Evolution of Medicine”. International leaders from politics, industry and the scientific community met in Berlin to discuss urgent aspects of global health. The World Health Summit was also the first event in a year of celebrations to mark the 300th anniversary of the Charité hospital in 2010. more

---

09/30/2009
Bayer Schering Pharma supports healthcare partnerships in developing countries
On Monday, September 21, 2009, in Berlin, about 40 representatives of nongovernmental organizations (NGOs), pharmaceutical companies, research institutions and development-aid initiatives discussed partnership initiatives aiming to improve healthcare in developing countries. The conference was jointly organized by Kreditanstalt für Wiederaufbau (KfW) and Bayer Schering Pharma AG. more

---

09/14/2009
Innovative Medicines Initiative: Putting Europe at the Forefront of Biopharmaceutical Innovation
Today, the Innovative Medicines Initiative (IMI), the public-private partnership between the European Commission and the European pharmaceutical industry, represented by EFPIA, made its first major announcement of the success of the collaboration. IMI announced the topics of research of its second call for proposals and introduced its newly-appointed Executive Director, Michel Goldman. more

---

09/10/2009
World Heart Day 2009 – Bayer teams up with World Heart Federation , 27th September 2009
Cardiovascular disease (CVD) remains the No. 1 cause of death worldwide — killing one person every two seconds. An estimated 17.5 million people died from CVD in 2005, and this number is expected to rise to 20 million by 2015. more

---

07/11/2009
Bayer Schering Pharma: Taking Social Responsibility in Family Planning
In 1994, the United Nations International Conference on Population and Development in Cairo reaffirmed that it is the basic human right of each individual to determine freely and responsibly the number and timing of their children. 15 years later, however, modern contraceptives remain out of reach for millions of people. more

---

07/09/2009
EFPIA press release on final European Commission report into the pharmaceutical sector
EFPIA, the association of the pharmaceutical industry in Europe, has decided to respond to the publication of the final European Commission report into the pharmaceutical sector on July 8, 2009 by issuing a press release. Commented Arthur J. Higgins, President of the EFPIA and CEO of HealthCare AG, “We have stated consistently that complex and divergent regulatory barriers are the primary cause of market entry delay for both generic and innovative medicines. We are pleased that the final report recognises this reality.” more

---

06/26/2009
Bayer Schering Pharma committed to efficient and safe drug development
The European pharmaceutical manufacturers’ association EFPIA and the European Commission launched the Innovative Medicines Initiative (IMI) in February 2008 with the aim of making the drug-development process more efficient and safer. more